Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of Ledipasvir/Sofosbuvir fixed-dose combination ± Ribavirin for chronic hepatitis C; the study is completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis C Virus | Phase 3 | Status: COMPLETED | Results posted: 2014-12-30